EarningsQ4 2022 Earnings Report

China Resources Pharmaceutical Group Ltd. (640) Q4 2022 Earnings Report

0 Followers

DE:640 Q4 2022 EPS Results

Actual EPS€0.02

Consensus EPS€0.02

Beat/MissMissed by -<€0.01

One Year Ago EPS€0.02

Actual Revenue€14.59B

Expected Revenue€16.35B

Beat/MissMissed by -€1.76B

YoY Revenue Growth+4.96%

QuarterQ4 2022

Date03/30/2023

TimeBefore Open

Conference CallThursday, March 30, 2023

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Aug 24, 2026	2026 (Q2)	0.05 / 0.05	0.044	6.06% (<+0.01)
Mar 25, 2026	2025 (Q4)	0.03 / 0.04	0.015	176.79% (+0.03)
Aug 26, 2025	2025 (Q2)	0.05 / 0.04	0.055	-19.51% (-0.01)
Mar 26, 2025	2024 (Q4)	0.03 / 0.01	0.022	-32.53% (>-0.01)
Oct 29, 2024	2024 (Q3)	- / -	0.059	―
Aug 29, 2024	2024 (Q2)	0.06 / 0.05	0.059	-8.07% (>-0.01)
Mar 26, 2024	2023 (Q4)	0.02 / 0.02	0.024	-7.26% (>-0.01)
Oct 30, 2023	2023 (Q3)	- / -	0.056	―
Aug 31, 2023	2023 (Q2)	- / 0.06	0.056	6.44% (<+0.01)
Mar 30, 2023	2022 (Q4)	0.02 / 0.02	0.019	4.68% (<+0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed